When and Who will get the first dose in India?: Harsh Vardhan to address key aspects of COVID-19 vaccine today

By Lokmat English Desk | Published: October 4, 2020 12:17 PM2020-10-04T12:17:50+5:302020-10-04T12:19:43+5:30

Union health minister Harsh Vardhan will on Sunday talk about when the country is likely to get a vaccine ...

When and Who will get the first dose in India?: Harsh Vardhan to address key aspects of COVID-19 vaccine today | When and Who will get the first dose in India?: Harsh Vardhan to address key aspects of COVID-19 vaccine today

When and Who will get the first dose in India?: Harsh Vardhan to address key aspects of COVID-19 vaccine today

Union health minister Harsh Vardhan will on Sunday talk about when the country is likely to get a vaccine against the coronavirus disease (Covid-19) and who will be the first to get the shots against the viral infection.In his weekly address Sunday Samvaad, the health minister will share the country’s way forward in tackling the coronavirus pandemic.“Tune-In tomorrow at 1PM to learn more about India’s #COVID19Vaccine plan ! When will we get #COVID19 vaccination? Who will be vaccinated first? What are the Government’s #COVID_19 immunization targets for Q2 2021? All these & more will be answered tomorrow on #SundaySamvaad!” Vardhan said in a tweet on Saturday.

Earlier, Harsh Vardhan had said the first vaccine for COVID-19 is likely to be available in the first quarter of 2021. "Research to develop a vaccine is being done expeditiously. There are at least three such viable vaccine candidates that are in the phase of clinical trials right now in the country. We are hopeful that within first quarter of 2021 it will be available," he had said.In India, the British-Swedish company AstraZeneca and the University of Oxford’s vaccine candidate being produced in collaboration with Pune-based pharma firm Serum Institute of India is in the third phase of trials while drugmaker Zydus Cadila launched phase 2 trials for its vaccine candidate on August 6. Another domestic pharma firm Bharat Biotech began phase 2 trials from September. According to the health ministry’s dashboard on Sunday still there are 937,625 active cases in the country.


 

Open in app